FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact

被引：0
|
作者：
Marianne Vogsen
Jeanette Dupont Jensen
Ivar Yannick Christensen
Oke Gerke
Anne Marie Bak Jylling
Lisbet Brønsro Larsen
Poul-Erik Braad
Katrine Lydolph Søe
Camilla Bille
Marianne Ewertz
Malene Grubbe Hildebrandt
机构：
[1] Odense University Hospital,Department of Oncology
[2] Odense University Hospital,Department of Nuclear Medicine
[3] University of Southern Denmark,Department of Clinical Research
[4] Odense University Hospital,Odense Patient Data Explorative Network
[5] Odense University Hospital,Centre for Personalized Response Monitoring in Oncology (PREMIO)
[6] Odense University Hospital,Department of Radiology
[7] Odense University Hospital,Department of Pathology
[8] Odense University Hospital,Department of Breast Surgery
[9] Odense University Hospital,Department of Plastic Surgery
[10] Odense University Hospital,Centre for Innovative Medical Technology
[11] Odense University Hospital,Department of Oncology and Department of Nuclear Medicine
来源：
Breast Cancer Research and Treatment | 2021年 / 185卷
关键词：
Breast cancer; FDG-PET/CT; Stage migration; Clinical impact; Incidental findings;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：145 / 153
页数：8
相关论文
共 50 条
  • [41] FDG-PET scanning impacts management in selected patients with high-risk breast carcinoma
    Port, ER
    Yeung, H
    Gonen, M
    Caravelli, J
    Liberman, L
    Borgen, PI
    Larson, S
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S33 - S34
  • [42] Validation of FDG-PET/MR imaging in gynecological cancer compared to standard clinical FDG-PET/CT
    Lofgren, J.
    Loft, A.
    Berthelsen, A. K.
    Hansen, A. E.
    Keller, S. H.
    Holm, S.
    Hojgaard, L.
    Beyer, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S370 - S371
  • [43] Integrated FDG-PET/CT for initial staging of breast cancer
    Khan, Q. J.
    O'Dea, A. P.
    Dusing, R.
    Sharma, P.
    Roling, S. M.
    Fabian, C. J.
    Kimler, B. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Initial experience with FDG-PET/CT in the evaluation of breast cancer
    Mitsuaki Tatsumi
    Christian Cohade
    Karen A. Mourtzikos
    Elliot K. Fishman
    Richard L. Wahl
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 254 - 262
  • [45] Initial experience with FDG-PET/CT in the evaluation of breast cancer
    Tatsumi, M
    Cohade, C
    Mourtzikos, K
    Fishman, EK
    Wahl, RL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (03) : 254 - 262
  • [46] The role of FDG-PET/CT in suspected recurrence of breast cancer
    Radan, Lea
    Ben-Haim, Simona
    Bar-Shalom, Rachel
    Guralnik, Luda
    Israel, Ora
    CANCER, 2006, 107 (11) : 2545 - 2551
  • [47] Evaluating the role of FDG-PET/CT in patients with high-risk bladder cancer being considered for radical treatment
    Hughes, F.
    Hughes, P.
    Chappell, B.
    Rankin, S.
    Khan, S.
    O'Brien, T.
    BJU INTERNATIONAL, 2010, 106 (01) : 9 - 9
  • [48] Assessment of clinicopathological subtype of breast cancer by FDG-PET/CT
    Miyake, K. K.
    Nakamoto, Y.
    Kanao, S.
    Tanaka, S.
    Togashi, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S283 - S283
  • [49] Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact
    Bonabi, Sharouz
    Schmidt, Felix
    Broglie, Martina A.
    Haile, Sarah R.
    Stoeckli, Sandro J.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2012, 269 (12) : 2555 - 2560
  • [50] The clinical utility of FDG-PET/CT in follow up and restaging of breast cancer patients
    Emad-Eldin, Sally
    Abdelaziz, Omar
    Harth, Marc
    Hussein, Manar
    Nour-Eldin, Nour-Eldin
    Vogl, Thomas J.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2013, 44 (04): : 937 - 943
12345